ConductScience.org, home

Paper25453091

(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.

Jiménez-Díaz MB and 49 others. Proc Natl Acad Sci U S A, 2014. Cited by 199 papers, by iCite.

Cite this record

ConductScience Library. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Papers, record 25453091. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25453091

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
199
iCite
Relative citation ratio, by iCite
7
iCite
Revised in PubMed
2023-08-29
PubMed

Authors50

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiménez-Díaz MBMaría Belén
2Ebert DDaniel
3Salinas YYandira
4Pradhan AAnupam
5Lehane AMAdele M
6Myrand-Lapierre MEMarie-Eve
7O'Loughlin KGKathleen G
8Shackleford DMDavid M
9Justino de Almeida MMariana
10Carrillo AKAngela K
11Clark JAJulie A
12Dennis ASAdelaide S M
13Diep JJonathon
14Deng XXiaoyan
15Duffy SSandra
16Endsley ANAaron N
17Fedewa GGreg
18Guiguemde WAW Armand
19Gómez MGMaría G
20Holbrook GGloria

Source PubMed

See all 50 authorsDownload CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
Calcium-Transporting ATPasesMajor topic
Heterocyclic Compounds, 4 or More RingsMajor topic
IsoquinolinesMajor topic
MalariaMajor topic
Models, MolecularMajor topic
PlasmodiumMajor topic
Cellular Senescence
Drug Discovery
Drug Resistance
Erythrocytes
Flow Cytometry
High-Throughput Screening Assays
Molecular Structure

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 AI075517NIAID NIH HHSUnited StatesU01AI075517PubMed and NIHNIH RePORTER
T32 GM067547NIGMS NIH HHSUnited StatesT32GM067547PubMed and NIHNIH RePORTER
T32 EB009383NIBIB NIH HHSUnited StatesT32EB009383PubMed and NIHNIH RePORTER
HHSN272201100022CNIAID NIH HHSUnited StatesPubMedPubMed
AI075517NIAID NIH HHSUnited StatesU01AI075517PubMed and NIHNIH RePORTER
HHSN2722011000221PHS HHSUnited StatesPubMedPubMed
P30 CA021765NCI NIH HHSUnited StatesP30CA021765PubMed and NIHNIH RePORTER
Howard Hughes Medical InstituteUnited StatesPubMedPubMed
AI090662NIAID NIH HHSUnited StatesR01AI090662PubMed and NIHNIH RePORTER
HHSN272201100022INIAID NIH HHSUnited StatesPubMedPubMed
R01 AI090662NIAID NIH HHSUnited StatesR01AI090662PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04709692Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax MalariaBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in26430239Correction for Jiménez-Díaz et al., (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.https://conductscience.org/library/papers/26430239

Source PubMed

Download CSV of comments and corrections

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116775118Assessment of erythrocyte shape by flow cytometry techniques.J Clin Pathol2007https://conductscience.org/library/papers/16775118PubMed
223742293Designing the next generation of medicines for malaria control and eradication.Malar J2013https://conductscience.org/library/papers/23742293PubMed
323798988The open access malaria box: a drug discovery catalyst for neglected diseases.PLoS One2013https://conductscience.org/library/papers/23798988PubMed
419267900CNV-seq, a new method to detect copy number variation using high-throughput sequencing.BMC Bioinformatics2009https://conductscience.org/library/papers/19267900PubMed
51503432Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1503432PubMed
620813948Spiroindolones, a potent compound class for the treatment of malaria.Science2010https://conductscience.org/library/papers/20813948PubMed
74008648Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.J Clin Invest1985https://conductscience.org/library/papers/4008648PubMed
819596869Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19596869PubMed
924523696Of macrophages and red blood cells; a complex love story.Front Physiol2014https://conductscience.org/library/papers/24523696PubMed
1022958514The global pipeline of new medicines for the control and elimination of malaria.Malar J2012https://conductscience.org/library/papers/22958514PubMed
116546931Adhesivity and rigidity of erythrocyte membrane in relation to wheat germ agglutinin binding.J Cell Biol1984https://conductscience.org/library/papers/6546931PubMed
123988747In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes.J Biol Chem1985https://conductscience.org/library/papers/3988747PubMed
1319710527Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria.Cell Physiol Biochem2009https://conductscience.org/library/papers/19710527PubMed
1422242845Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials.Curr Top Med Chem2012https://conductscience.org/library/papers/22242845PubMed
1525075833Spiroindolone KAE609 for falciparum and vivax malaria.N Engl J Med2014https://conductscience.org/library/papers/25075833PubMed
1622318405Microfluidic biomechanical assay for red blood cells parasitized by Plasmodium falciparum.Lab Chip2012https://conductscience.org/library/papers/22318405PubMed
1723414762Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials.Cell Host Microbe2013https://conductscience.org/library/papers/23414762PubMed
183044154X-ray microanalysis of Plasmodium falciparum and infected red blood cells: effects of qinghaosu and chloroquine on potassium, sodium, and phosphorus composition.Am J Trop Med Hyg1988https://conductscience.org/library/papers/3044154PubMed
1921427291Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver.Blood2011https://conductscience.org/library/papers/21427291PubMed
2023715326Genome sequencing sheds light on emerging drug resistance in malaria parasites.Nat Genet2013https://conductscience.org/library/papers/23715326PubMed

See all 29 referencesDownload CSV of references

Cited by139

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 199 citations.

PMIDTitleJournalYearIn PapersSource
42006802Mechanistic perspectives on antimalarial agents: from FDA-approved drugs to next-generation candidates.RSC Adv2026https://conductscience.org/library/papers/42006802PubMed
41980931Potent acridone antimalarial against all three life stages of Plasmodium.Nat Commun2026https://conductscience.org/library/papers/41980931PubMed
41484625Natural triterpenic phenolic esters target PfA-M17 in Plasmodium falciparum.Malar J2026https://conductscience.org/library/papers/41484625PubMed
41441052Impacts of Cipargamin on Na+-ATPase and Osmoregulation of Trypanosoma cruzi.Membranes (Basel)2025https://conductscience.org/library/papers/41441052PubMed
41178292The impact of phenotypic- versus target-based approaches in antimalarial drug discovery in the last two decades (2005-2025).Future Med Chem2025https://conductscience.org/library/papers/41178292PubMed
41144577PfATP2 is a flippase on the Plasmodium falciparum surface that is important for growth and influences parasite sensitivity to antiplasmodial compounds.PLoS Pathog2025https://conductscience.org/library/papers/41144577PubMed
41115914Endogenous structure of antimalarial target PfATP4 reveals an apicomplexan-specific P-type ATPase modulator.Nat Commun2025https://conductscience.org/library/papers/41115914PubMed
41002306Pathophysiological Associations and Measurement Techniques of Red Blood Cell Deformability.Biosensors (Basel)2025https://conductscience.org/library/papers/41002306PubMed
40921413Identification of α-Azacyclic Acetamide-Based Inhibitors of P. falciparum Na+ Pump (PfATP4) with Fast-Killing Asexual Blood-Stage Antimalarial Activity by Phenotypic Screening.ACS Infect Dis2025https://conductscience.org/library/papers/40921413PubMed
40921080Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity.J Med Chem2025https://conductscience.org/library/papers/40921080PubMed
40715087An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs.Nat Commun2025https://conductscience.org/library/papers/40715087PubMed
40523953Malaria: past, present, and future.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40523953PubMed
40228810Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4.J Med Chem2025https://conductscience.org/library/papers/40228810PubMed
39773028Mutational analysis of an antimalarial drug target, PfATP4.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/39773028PubMed
39738025Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibility.Nat Commun2024https://conductscience.org/library/papers/39738025PubMed
39723908TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance.J Med Chem2025https://conductscience.org/library/papers/39723908PubMed
39607932Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance.Science2024https://conductscience.org/library/papers/39607932PubMed
39548094Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials.Nat Commun2024https://conductscience.org/library/papers/39548094PubMed
39264187An adaptable, fit-for-purpose screening approach with high-throughput capability to determine speed of action and stage specificity of anti-malarial compounds.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/39264187PubMed
39210733Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4.ChemMedChem2024https://conductscience.org/library/papers/39210733PubMed

See all 139 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DNAH81769PubTator's text mininghttps://conductscience.org/library/genes/1769

Source NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
BioProjectPRJNA253899

Source BioProject

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25453091

GET https://conductscience.org/api/papers/v1/25453091/authors?page=2